Entrada Therapeutics Inc (TRDA) Q2 2024 Earnings Report

166 Followers

TRDA Q2 2024 EPS Results

Actual EPS$1.55

Consensus EPS$0.36

Beat/MissBeat by +$1.19

One Year Ago EPS-$0.78

Actual Revenue$94.69M

Expected Revenue$51.86M

Beat/MissBeat by +$42.83M

YoY Revenue Growth+421.16%

QuarterQ2 2024

Date08/13/2024

TimeBefore Open

Conference CallTuesday, August 13, 2024

TRDA Upcoming Earnings

Entrada Therapeutics Inc's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 10, 2026	2026 (Q3)	-1.01 / -	-1.06	―
Aug 05, 2026	2026 (Q2)	-1.05 / -1.01	-1.04	2.88% (+0.03)
May 07, 2026	2026 (Q1)	-1.04 / -0.95	-0.42	-126.19% (-0.53)
Feb 26, 2026	2025 (Q4)	-1.15 / -0.94	0.03	-3233.33% (-0.97)
Nov 06, 2025	2025 (Q3)	-0.94 / -1.06	-0.35	-202.86% (-0.71)
Aug 06, 2025	2025 (Q2)	-0.85 / -1.04	1.55	-167.10% (-2.59)
May 08, 2025	2025 (Q1)	-0.79 / -0.42	0.68	-161.76% (-1.10)
Feb 27, 2025	2024 (Q4)	-0.67 / 0.03	-0.29	110.34% (+0.32)
Nov 05, 2024	2024 (Q3)	-0.73 / -0.35	1.02	-134.31% (-1.37)
Aug 13, 2024	2024 (Q2)	0.36 / 1.55	-0.78	298.72% (+2.33)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed